MAY 15-17 "ONCOLIX" PARTICIPATED IN US/CHINA_INNOVATION_&_INVESTMENT_SUMMIT!!! https://www.b2match.eu/ucis2017/participants/24 – PRIVATE COMPANY "ONCOLIX" RECENTLY PURCHASED PUBLIC SHELL COMPANY "AEPP". – "ONCOLIX" HAS 8 PATENTS IN U.S. AND PATENTS IN OTHER COUNTRIES. – ALL "AEPP" DEBT WAS PAID OFF BY "ONCOLIX" AT PURCHASE. – "AEPP" HAS A LOW FLOAT: 33,311,633 a/o Apr 06, 2017 PER OTCMARKETS.COM: https://www.otcmarkets.com/stock/AEPP/profile – "ONCOLIX" HAS ORPHAN DRUG "PROLANTA" CURRENTLY IN FDA-APPROVED PHASE 1 TRIALS. – INVENTOR OF "PROLANTA" ALSO INVENTED "SOMAVERT" SOLD BY PFIZER. "SOMAVERT" YIELDED $232M IN REVS LAST YEAR. – APRIL 2017 "ONCOLIX" COMPANY PRESENTATION: https://nebula.wsimg.com/8b544fcbb6f5bf5fb52c1c7e5a69eb81?AccessKeyId=D34B304F5C474C27E878&disposition=0&alloworigin=1 – BRAND NEW "ONCOLIX" WEBSITE: https://www.oncolixbio.com/home.html – VERY IMPRESSIVE "ONCOLIX" CEO INTERVIEW (4/24/17)>>> https://www.youtube.com/watch?v=Ox6n1HH8v_0&feature=youtu.be